Cargando…
Predicting lithium treatment response in bipolar patients using gender-specific gene expression biomarkers and machine learning
Background: We sought to test the hypothesis that transcriptome-level gene signatures are differentially expressed between male and female bipolar patients, prior to lithium treatment, in a patient cohort who later were clinically classified as lithium treatment responders. Methods: Gene expression...
Autores principales: | Eugene, Andy R., Masiak, Jolanta, Eugene, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381805/ https://www.ncbi.nlm.nih.gov/pubmed/30828420 http://dx.doi.org/10.12688/f1000research.14451.3 |
Ejemplares similares
-
Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004–2020
por: Eugene, Andy R., et al.
Publicado: (2021) -
Pharmacogenomics of Lithium Response in Bipolar Disorder
por: Vecera, Courtney M., et al.
Publicado: (2021) -
Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response
por: Geoffroy, Pierre Alexis, et al.
Publicado: (2014) -
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
por: Marie-Claire, Cynthia, et al.
Publicado: (2022) -
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study
por: Marie-Claire, C., et al.
Publicado: (2023)